İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi

Yıl 2003, Cilt: 1 Sayı: 1, 92 - 95, 01.09.2003

Sara Şebnem Kılıç

Öz

Standart intravenöz immunglobulin IVIG preparatları yaklaşık olarak 5000-10000 donör plazmasından elde edilmektedir. Çok sayıda donörden hazırlanması nedeniyle donörlerin doğal enfeksiyon ve immunizasyon ile oluşmuş çok çeşitli tipteki antikorlarını içerirler

Kaynakça

• 1. Schwartz SA. Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatr Clin North Am 2000; 47(6): 1355-1369.
• 2. Schwartz SA. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol 1990; 10: 81-89.
• 3. Douzinas EE, Pitaridis MT. Secondary antibody deficiency states. Crit Care Med 2000; 28: 8-15.
• 4. Bruton O. A Gammaglobulinemia. Pediatrics 1952; 9: 722- 728.
• 5. Minegishi R, Rohrer J, Conley ME. Recent progress in the diagnosis and treatment of patients with defects in early B-cell development. Curr Opin Pediatr 1999; 11: 528-532.
• 6. Cunningam-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
• 7. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-Ig M syndrome. J Pediatr 1997; 131: 47-54.
• 8. Gardulf A, Hammarstrom L, Smith CIE. Home treatment of hypogammaglobulinemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991; 338:162-166.
• 9. Misbah SA, Spickett GA, Ryba PC, et al. Chronic enteroviral meningoenephalitis in agammaglobulinemia. J Clin Immunol 1992; 12: 266-270.
• 10. Duhem C, Dicato MA, Ries F. Side effects of intravenous immuno globulins. Clin Exp Immunol 1994; 97: 79-83.
• 11. Anonymous. Renal insufficiency and failure associated with immunoglobulin intra venous therapy-United States, 1985-1998. MMWR 1999; 48: 518-521.
• 12. Tam DA, Morton LD, Stroncek DF, et al. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996; 64:175-178.
• 13. Brox AG, Cournoyer D, Sternbach M, et al. Hemolytic anemia following intravenous gammaglobulin administration. Am J Med 1987; 82: 633-635.
• 14. Kessary-Shoham H, Levy Y, Shoenfeld Y, et al. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration. J Autoimmun 1999; 13:129-135.
• 15. Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 1997;20:1102-1107.
• 16. Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000;75:83-85.
• 17. Bertorini TE, Nance AM, Homer LH, et al. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 1996;19:388-391.
• 18. Lisak RP. Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1996;135:85-88.
• 19. Siber GR, Werner BG, Halsey NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr 1993;122:204-211.